China Biopharmaceuticals Holding Inc. (CHBP.OB) Posts 78 Percent Increase in Q1 Revenue
China Biopharmaceuticals Holding Inc. (OTCBB: CHBP) focuses on the discovery, development, manufacturing and marketing of pharmaceutical products in the People’s Republic of China. Today the company announced its first quarter results for the period ended March 31, 2008. China Biopharmaceuticals posted first quarter revenue at $10.9 million, up 78 percent from $6.1 million last year. The company attributes the increase to the rise in price and sales of its raw material drugs at its main manufacturing plant, Erye; the revamped medical insurance system in China, promoting Erye’s drugs; and the increased price of freeze-dried drugs. Net income was $492,076 for…